Taro-Dermovate & Taro-Clobetasol Cream Recall [Canada]

Canada FlagCanada/Ottawa: Logo - Taro Pharmaceuticals IncTaro Pharmaceuticals Inc, a Brampton, Ontario establishment and subsidiary of Taro Pharmaceutical Industries Ltd. of Haifa, Israel recalls certain batch/lots of Taro-Dermovate Cream and Taro-Clobetasol Cream USP from the Canadian marketplace due to suspected product mixing irregularities and consequential risk of failure to meet content uniformity standards with possible under- and/or over-dose administration, all serious health and safety hazards.

HCSC: http://ht.ly/myJ930r1o7K

Direct link: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73615r-eng.php

Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following Drugs are subject to this recall:

Continue reading

Lupin Pharma Metformin Hydrochloride Tablet Recall [US]

Lupin Pharma Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US FlagUS/Silver Spring: Lupin Pharmaceuticals, Inc., a Baltimore, Maryland establishment, recalls all current batch/lots of Lupin Pharma branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/NuJP30qY97Z

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Continue reading

Granules Pharma Metformin Hydrochloride Recall [US]

Granules Pharma Metformin Hydrochloride Recall [US]

Click to enlarge image

US FlagUS/Silver Spring: Granules Pharmaceuticals, Inc., a Chantilly, Virginia establishment, recalls twelve (12) batch/lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/dXLm30qX5hG

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/granules-pharmaceuticals-inc-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Continue reading

Apotex Metformin Hydrochloride Tablet Recall [Canada]

Apotex Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

Canada FlagCanada/Ottawa: Apotex Corp., a Toronto, Ontario establishment, recalls certain batch/lots of Apotex Corp branded Metformin Hydrochloride Extended-Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable Health Canada levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

HCSC: http://ht.ly/RIm630qRn75

Direct link: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73339r-eng.php

Additional information:
The Health Canada (“HCSC) reports the following Metformin medications are subject to this recall:

Continue reading

Lupin Pharma Metformin Hydrochloride Tablet Recall [US]

Lupin Pharma Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US FlagUS/Silver Spring: Lupin Pharmaceuticals, Inc., a Baltimore, Maryland establishment, recalls certain batch/lots of Lupin Pharma branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/GfnZ30qQfdN

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-one-lot-metformin-hydrochloride

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Continue reading

Apotex Metformin Hydrochloride Tablet Recall [US]

Apotex Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US FlagUS/Silver Spring: Apotex Corp., a Toronto, Ontario establishment, recalls certain batch/lots of Apotex Corp branded Metformin Hydrochloride Extended-Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/HmUE30qPhSK

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/apotex-corp-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended-release-tablets

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Continue reading

Actavis Pharma Metformin Hydrochloride Tablet Recall [US]

Actavis Pharma Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US FlagUS/Silver Spring: Teva Pharmaceuticals USA, Inc., a Parsippany, New Jersey establishment and subsidiary of Teva Pharmaceutical Industries Ltd. of Petah Tikva, Israel, recalls certain batch/lots of Actavis Pharma, Inc. branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/q9Pu30qOed1

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-pharmaceuticals-usa-inc-initiates-voluntary-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Continue reading

Time-Cap Labs Metformin Hydrochloride Tablet Recall [US]

Time-Cap Labs Metformin Hydrochloride Tablet Recall [US]

Click to enlarge image

US FlagUS/Silver Spring: Marksans Pharma Limited, a Verna, Goa, India establishment, recalls certain batch/lots of Time-Cap Labs, Inc. branded Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/upL630qNRGM

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/marksans-pharma-limited-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended-release

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Continue reading

Amneal Metformin Hydrochloride Tablet Recall [US]

Logo - Metformin Hydrochloride Extended Release Tablets

Click to enlarge image

US FlagUS/Silver Spring: Amneal Pharmaceuticals LLC, a Bridgewater, New Jersey establishment, recalls all current batch/lots of Metformin Hydrochloride Extended Release Tablets from the American marketplace due to suspected N-Nitrosodimethylamine (“NDMA”) contamination in amounts above acceptable FDA levels with consequential risks of Cancer, severe illness and/or possible life-changing complications, all serious health hazards.

FDA: http://ht.ly/pU8030qNxkW

Direct link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-voluntary-nationwide-recall-metformin-hydrochloride-extended

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Metformin medications are subject to this recall:

Continue reading

Apotex APO-Metformin Diabetes Medication Recall [Canada]

Canada FlagCanada/Ottawa: Logo - Apotex Inc.Apotex Inc., a Toronto, Ontario establishment, recalls certain batch/lots of the APO-Metformin ER Diabetes medication from the Canadian marketplace due to levels of Nitrosamines (“NDMA”) in excess of Canadian health regulations and consequential long-term risk of certain forms of Cancer, all serious health and safety hazards.

HCSC: http://ht.ly/O6Bt30qfPEy

Direct link: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72287a-eng.php

Additional information:
Health Canada/Santé Canada (“HCSC”) reports the following medications are subject to this recall:

Continue reading

%d bloggers like this: